07:35 AM EDT, 06/02/2025 (MT Newswires) -- InMed Pharmaceuticals ( INM ) shares were up more than 200% pre-bell Monday following a muted session.

Vera Therapeutics ( VERA ) shares were 75% higher after the company said its phase 3 trial of atacicept for the treatment of immunoglobulin A nephropathy achieved its primary endpoint.

Instill Bio (TIL) shares were more than 46% higher after the company said it has appointed Jamie Freedman as chief medical officer.

Black Spade Acquisition II ( BSII ) stock was up 16% after the blank check company said late Friday its shareholders approved a pending business combination with The Generation Essentials Group.